Test Menu

MaterniT 21 PLUS

The pioneering NIPS (NIPT) with more than 1 million tests run; screens the core trisomies 21, 18, and 13, and (optionally) fetal sex, clinically relevant microdeletions, sex chromosome aneuploidies, and trisomies 16 and 22.

MaterniT® Genome

The only clinically validated genome-wide NIPS (NIPT) screens all 23 chromosome pairs, reporting aneuploidies, large deletions and duplications greater than 7 Mb in addition to select microdeletions; after more than 35,000 tests resulted, more than 29% of all positive findings were only detectable using genome-wide cfDNA, the methodology used by MaterniT GENOME, as compared to traditional NIPS (NIPT).¹

VistaSeq

VistaSeq is a multi-gene assay for genetic mutations known to be associated with an increased risk of developing hereditary cancers. With 12 test panels, the VistaSeq Hereditary Cancer portfolio helps you give patients more—and more critical—information.

Inheritest®

Inheritest® provides carrier screening for more than 500 genes that can cause cognitive or physical impairment and/or require surgical or medical intervention.

Selected to focus on severe disorders of childhood-onset, and to meet ACOG and the American College of Medical Genetics and Genomics (ACMG) criteria, many of the disorders share a recommendation for early intervention.

Reveal® SNP Microarray

Labcorp SNP microarray has applications for pediatric (cord blood, peripheral blood, and buccal swab), prenatal (amniotic fluid and chorionic villus), and POC (fresh tissue and formalin-fixed paraffin-embedded) sample types.